Skip to content

AQUABEAM Robotic System Use-Results Survey

AQUABEAM Robotic System Use-Results Survey - AQUABEAM Robotic System Use-Results Survey

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000051331
Enrollment
100
Registered
2023-07-01
Start date
2023-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients for whom the Product is used in accordance with the approved purpose of use, indication or effect, method of use and the Appropriate Use Guideline.

Interventions

None listed

Sponsors

Vorpal Technologies K.K
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Patients undergoing prostatectomy with the AQUABEAM Robotic System in men with lower urinary tract symptoms due to benign prostatic hyperplasia

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

MeasureTime frame
-IPSS score change from baseline up to 3 months -Percentage of patients leading to blood transfusions or Clavien-Dindo 3 or higher adverse events up to 30 days after the procedure

Countries

Japan

Contacts

Public ContactSatoko Inoue

Vorpal Technologies K.K Regulatory Affairs

Satoko.Inoue@mcra.com+81(3)5544-8340

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026